Dr. Nicole Denig M.D.

Dr. Nicole Denig, MD, is a seasoned dermatologist currently practicing at Havelland Kliniken GmbH since July 2019. With a diverse background in dermatological and pharmaceutical fields, Dr. Denig previously held the position of Global Safety Leader in Risk Management and Pharmacovigilance at Bayer Pharmaceuticals from July 2013 to June 2019 and served as a Medical Advisor at Intendis/Bayer Dermatology from January 2006 to July 2013. Earlier in their career, Dr. Denig worked as a Project Manager and Investigator at proDERM and practiced as a board-certified dermatologist and allergologist at Universitäts-Hautklinik Freiburg. Additionally, Dr. Denig contributed to research as a Research Fellow at the University of California, San Francisco. Dr. Denig earned a Doctor of Medicine degree from Heidelberg University and has furthered education at prestigious institutions including the University of California, San Francisco, the University of Strasbourg, and Universität des Saarlandes.